A Phase I/II, Open-Label, Multicenter, Dose Escalation and Dose Expansion Study of NKTR-214 in Subjects with Locally Advanced or Metastatic Solid Tumor Malignancies

What is the purpose of this trial?

To evaluate the safety and tolerability, and define the maximum tolerated dose (MTD) of NKTR-214 in locally advanced, solid tumors.

Participation Guidelines

Ages: 18 years and older

Gender: Both

Nektar Therapeutics

Dates: 01/20/2016 - 09/01/2017

Last Updated: 07/30/2017

Study HIC#: 1508016326